Results 31 to 40 of about 98,021 (296)

Immunomodulatory effects of Blaps rynchopetera extract [PDF]

open access: yesActa Cirúrgica Brasileira, 2022
Purpose: To explore the potential immunomodulatory effects of total extract and different polar parts from Blaps rynchopetera Fairmaire. Methods: Phagocytic activity was evaluated by neutral red assay, and the effect of the immune function was ...
Di Meng   +9 more
doaj   +1 more source

Bullous Scabies in an Immunocompromised Host

open access: yesCase Reports in Infectious Diseases, 2022
A 40-year-old woman with a history of poorly controlled HIV presented to a district referral hospital in rural Botswana for a generalized skin rash of several months duration.
James R. Wester   +4 more
doaj   +1 more source

Antigenic evolution of SARS-CoV-2 in immunocompromised hosts [PDF]

open access: yes, 2023
Prolonged infections of immunocompromised individuals have been proposed as a crucial source of new variants of SARS-CoV-2 during the COVID-19 pandemic. In principle, sustained within-host antigenic evolution in immunocompromised hosts could allow novel ...
Smith, Cameron, Ashby, Ben
core   +1 more source

Antiretroviral resistance in HIV-1 patients at a tertiary medical institute in Saudi Arabia: a retrospective study and analysis

open access: yesBMC Infectious Diseases, 2018
Background Since the early 90’s antiretroviral drugs have been available at King Faisal Specialist Hospital and Research Centre (KFSH&RC), a referral hospital in Riyadh, Saudi Arabia, for the treatment of both adults and children infected with HIV-1 ...
Maha Al-Mozaini   +3 more
doaj   +1 more source

The Conditions of Primary Infection Define the Load of Latent Viral Genome in Organs and the Risk of Recurrent Cytomegalovirus Disease [PDF]

open access: yes, 1994
Recurrence of cytomegalovirus (CMV) from latency is a frequent cause of disease in immunocompromised patients. To date, there is no explanation for the diversity in the clinical manifestations.
Balthesen, Monika   +16 more
core   +1 more source

SARS-CoV-2 intra-host evolution during prolonged infection in an immunocompromised patient [PDF]

open access: yes, 2022
Objectives: Intra-host SARS-CoV-2 evolution during chronic infection in immunocompromised hosts has been suggested as being the possible trigger of the emergence of new variants.
Matteo Pagliari   +25 more
core   +1 more source

Nocardia empyema in an immunocompromised host: A case report. [PDF]

open access: yesRespir Med Case Rep
Patients with myeloproliferative disorders such as primary myelofibrosis are at an increased risk of opportunistic infections including Nocardia pneumonia.
Reyna CIR   +5 more
europepmc   +2 more sources

Adenoviruses in Immunocompromised Hosts [PDF]

open access: yesClinical Microbiology Reviews, 2008
SUMMARYThe number of patients with acquired immunodeficiency has grown steadily as a result of both a larger number of patients receiving solid organ and hematopoietic stem cell transplants and their longer survival times. The use of newer, more potent immunosuppressive regimens has increased the frequency of severe adenovirus infections.
openaire   +2 more sources

Adhesion and host cell modulation: critical pathogenicity determinants of Bartonella henselae [PDF]

open access: yes, 2011
Bartonella henselae, the agent of cat scratch disease and the vasculoproliferative disorders bacillary angiomatosis and peliosis hepatis, contains to date two groups of described pathogenicity factors: adhesins and type IV secretion systems.
Kempf Volkhard AJ   +5 more
core   +1 more source

CENTRAL NERVOUS SYSTEM TOXOPLASMOSIS IN CHILDREN WITHOUT HUMAN IMMUNODEFICIENCY VIRUS INFECTION [PDF]

open access: yesActa Medica Iranica, 1999
Toxoplasma EncepfiaUtis (TE) is rare in pediatric patients, but it is an emerging opportunistic infection in the increasing number of immunocompromised hosts. It should be considered in patients who present with fever and evolving CNS symptoms.
Gh. Khotaei
doaj   +1 more source

Home - About - Disclaimer - Privacy